ARCHIVES

NCI Funding Notice.

This article is from The Cancer Letter archive.

Vol. 29 No. 27 | July 4, 2003

Download PDF Visit The Full Archive

Related Articles

Degarelix Active In Phase II Trial In Prostate Cancer

October 29, 2004

Controversy Continues, Scientists, Advocates, Clinicians Say

January 31, 1997

New FDA Commisioner’s Top Priorities: FDAMA Implimitation, Agency’s Science

January 8, 1999

Panel Considers Easing Comp Center Independence Requirement, but Realizes It Lacks That Authority

February 18, 1977

Centers Of Excellence In Interventions Aimed at molecular Targets; Approved On 19-6 Vote

July 2, 1999

NCI Advisory Group, Other Cancer Meetings

February 28, 1986